[In the News] Executive Director Marjorie A. Speers, Ph.D., Speaks Out on Need for Diversity in COVID-19 Vaccine Trials

August 10, 2020|Categories: News|

Clinical Research Pathways Executive Director Marjorie A. Speers, Ph.D., an epidemiologist and longstanding advocate for diversity in clinical research, has been featured in a number of news stories on the need to include Black and Latino participants in COVID-19 vaccine trials. To do otherwise, will “end up creating a greater health disparity,” she says.

Why Diversity Matters In COVID-19 Vaccine Trials

Verywell Health, Published August 29, 2020

[News] FDA Streamlines Process for Single Patient Expanded Access During Pandemic

June 8, 2020|Categories: News|

The Food and Drug Administration (FDA) has issued new Expanded Access guidance to help physicians understand and use the Expanded Access process to treat patients with investigational drugs and biologics during the COVID-19 public health emergency. 

The new guidance allows physicians applying for single patient expanded access to request a waiver of the FDA requirement for full institutional review board (IRB) review. If the waiver is granted, the […]

[News Release] Clinical Research Pathways Partners with WellStar Health System to Increase Diversity in Clinical Trials

December 12, 2019|Categories: News|

Grant to promote minority participation in cancer research

ATLANTA, December 12, 2019—Clinical Research Pathways is partnering with WellStar Health System to increase diversity in oncology research to help ensure that new cancer medicines are effective for patients of all races and ethnicities.

The two organizations—a nonprofit focused on creating pathways to new medicines and treatments, and one of Georgia’s largest health systems—will develop strategies to enroll more minority patients in oncology trials. […]

Clinical Research Pathways Submits Comments on FDA Draft Guidance on Diversity in Clinical Trials

September 9, 2019|Categories: News|

Marjorie A. Speers, Ph.D., executive director of Clinical Research Pathways, recently submitted comments on FDA draft guidance on enhancing the diversity of clinical trial populations. The comments reflect Clinical Research Pathways’ commitment to enrolling more minority patients in clinical research. If the demographic mix of clinical trial participants mirrors that of the population as a whole, data on new medicines will reflect the effectiveness and potential […]

[News Release] Clinical Research Pathways Taps Emory Physician for Board of Directors

May 29, 2019|Categories: News|

Dr. Derek West chosen for clinical research and mentoring experience

ATLANTA, May 30, 2019Clinical Research Pathways has appointed Dr. Derek West, cancer researcher and interventional radiologist, to its board of directors.

He joins six other directors, all chosen for their commitment to Clinical Research Pathways’ goals of increasing diversity in clinical research and expanding access to experimental drugs, biologics and medical devices.

West is an associate professor […]

[News Release] Clinical Research Pathways Names Two New Directors

February 25, 2019|Categories: News|

Attorney Keith Barnett and Rev. Dr. Jason E. Owen Join Nonprofit Board

ATLANTA, February 26, 2019 Clinical Research Pathways has appointed two new members to its board of directors: Attorney Keith Barnett, a partner in the national law firm Troutman Sanders, and Rev. Dr. Jason E. Owen, chief apostle and international presiding bishop of Biblical Deliverance Ministries.

[News Release] Morehouse School of Medicine Awarded $200,000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials

September 20, 2018|Categories: News|

Funded by Clinical Research Pathways, the New Program Intends to Fill a Gap in the Percentage of Minorities Who Participate in Clinical Trials

ATLANTA, September 20, 2018 — Morehouse School of Medicine (MSM) will launch a program specifically designed to increase the number of African American, Latino and other minority patients in clinical trials, in an effort that could eventually lead to the development of medical treatments better tailored for those […]

Seeking Physician Input on Using Expanded Access To Experimental Drugs for Their Patients

June 26, 2018|Categories: News|

*Update: This assessment is now closed. Click here to see the results.*

Clinical Research Pathways Needs Assessment Survey Aims to Assist Physicians

ATLANTA, Ga., June 26, 2018— Clinical Research Pathways has launched an effort to learn what information and other resources physicians need to seek access to experimental drugs for desperately ill or terminal patients, using the expanded access program.

Under the U.S. Food and Drug Administration’s […]

Clinical Research Pathways Names Two New Directors

June 5, 2018|Categories: News|

ATLANTA, Ga., June 5, 2018 — Clinical Research Pathways has appointed two new members to its board of directors: Anne B. Cropp of Early Access Care and Andrew McFadyen of The Isaac Foundation and Equal Access for Rare Disorders.

The former WCG Foundation, Clinical Research Pathways is a public charity that works to improve health and well-being for all by creating pathways to new medicines. The organization seeks to increase diversity in […]

Republicans Get Ready to Vote on “Right-to-Try” Bill Again

March 19, 2018|Categories: News|

Published March 19, 2018 by The American Journal of Managed Care

The right-to-try bill, which suffered a surprise 259-140 defeat in the House of Representatives last week, is scheduled for another vote this week, perhaps as early as Wednesday.

On Monday, the House Committee on Rules was scheduled to meet late in the day to change the procedure so that it could be passed with just a simple majority, rather than a […]

Load More Posts
Go to Top